Evofem Biosciences, Inc.

OTC:EVFM

Pharmaceutical Preparations·SAN DIEGO, CA

CEO

Pelletier Saundra L

CFO

Zhang Yan

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/13/25	→
10-Q	Q2 2025	6/30/25	8/14/25	→
10-Q	Q1 2025	3/31/25	5/15/25	→
10-K/A	FY 2024	12/31/24	3/28/25	→
10-K	FY 2024	12/31/24	3/24/25	→
10-Q	Q3 2024	9/30/24	11/14/24	→
↓

Earnings Releases (8-K)

15 shown

Filed	Period
11/13/25	Q4 FY2025	→
8/14/25	Q3 FY2025	→
5/15/25	Q2 FY2025	→
3/24/25	Q1 FY2025	→
11/14/24	Q4 FY2024	→
8/14/24	Q3 FY2024	→
↓

News (8-K)

65 shown

Filed	Type	Description
1/12/26	Reg FD	Regulation FD Disclosure	→
11/26/25	Vote	Amendments to Articles of Incorporation or Bylaws	→
10/20/25	Reg FD	Termination of a Material Definitive Agreement	→
10/17/25	Agreement	Entry into a Material Definitive Agreement	→
8/26/25	Agreement	Entry into a Material Definitive Agreement	→
7/2/25	Agreement	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
8/14/23	424B3	424B3	→
8/11/23	S-1/A	S-1/A	→
8/3/23	S-1/A	S-1/A	→
7/10/23	S-1	S-1	→
9/30/22	424B3	424B3	→
9/23/22	S-1	S-1	→
↓

Filing History(789 filings)

TypeDateAccessionPeriodSize

8-K

Jan 12, 2026

0001493152-26-0018868-K

Jan 12, 2026

13.9 MB

8-K

Nov 26, 2025

0001493152-25-0251728-K

Nov 26, 2025

239.5 KB

8-K

Nov 13, 2025

0001493152-25-0223188-K

Nov 13, 2025

275.4 KB

10-Q

Nov 13, 2025

0001493152-25-02227510-Q

Sep 30, 2025

9.3 MB

DEF 14A

Oct 29, 2025

0001493152-25-020062DEF 14A

Oct 29, 2025

10.6 MB

PRE 14A

Oct 20, 2025

0001493152-25-018688PRE 14A

Oct 20, 2025

2.8 MB

8-K

Oct 20, 2025

0001493152-25-0186878-K

Oct 20, 2025

277.0 KB

8-K

Oct 17, 2025

0001493152-25-0184548-K

Oct 13, 2025

226.3 KB

DEFA14A

Sep 19, 2025

0001493152-25-014327DEFA14A

—

16.4 MB

DEFA14A

Sep 9, 2025

0001641172-25-026967DEFA14A

—

44.0 KB

DEFM14A

Sep 8, 2025

0001641172-25-026774DEFM14A

—

11.0 MB

PREM14A

Aug 26, 2025

0001641172-25-025582PREM14A

Aug 26, 2025

7.1 MB

8-K

Aug 26, 2025

0001641172-25-0255308-K

Aug 22, 2025

851.7 KB

10-Q

Aug 14, 2025

0001641172-25-02374110-Q

Jun 30, 2025

9.8 MB

8-K

Aug 14, 2025

0001641172-25-0237408-K

Aug 14, 2025

321.0 KB

DEF 14C

Aug 6, 2025

0001641172-25-022301DEF 14C

Aug 5, 2025

452.9 KB

PREM14A

Jul 24, 2025

0001641172-25-020836PREM14A

Jul 24, 2025

5.9 MB

PRE 14C

Jul 9, 2025

0001641172-25-018412PRE 14C

Jul 9, 2025

453.1 KB

8-K

Jul 2, 2025

0001641172-25-0175638-K

Jun 26, 2025

1.2 MB

Jul 2, 2025

0001641172-25-017535

—

9.3 KB

8-K

May 22, 2025

0001641172-25-0119628-K

May 19, 2025

538.7 KB

10-Q

May 15, 2025

0001641172-25-010529

Mar 31, 2025

8.0 MB

8-K

May 15, 2025

0001641172-25-0105268-K

May 15, 2025

298.0 KB

8-K

May 8, 2025

0001641172-25-0092488-K

May 3, 2025

247.7 KB

Apr 15, 2025

0001641172-25-004770

—

9.3 KB

25 filings shown

Evofem Biosciences, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(789 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
10/29/25	DEF 14A	DEF 14A	→
10/20/25	PRE 14A	PRE 14A	→
9/19/25	DEFA14A	DEFA14A	→
9/9/25	DEFA14A	DEFA14A	→
9/8/25	DEFM14A	DEFM14A	→
8/26/25	PREM14A	PREM14A	→
↓

Filed	Form	Description
2/14/24	SC 13G/A	SC 13G/A	→
1/12/24	4	4	→
12/22/23	4	4	→
5/8/23	5	5	→
4/26/23	4	4	→
4/26/23	3	FORM 3	→
↓

Filed	Form	Description
7/2/25	D	D	→
4/15/25	D	D	→
8/21/24	D	D	→
8/21/24	D	D	→
10/11/23	D	D	→
8/18/23	PRER14A	PRER14A	→
↓